The effect of Vitilexine Cream Givrelle in comparison with placebo in the treatment of patients with vitiligo undergoing phototherapy
Phase 2
Recruiting
- Conditions
- Vitiligo.Vitiligo
- Registration Number
- IRCT20150825023753N21
- Lead Sponsor
- Shiraz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 35
Inclusion Criteria
The patient's age is over 18 years
The presence of at least 2 vitiligo corneal lesions in the upper, lower limbs, face or trunk that are similar in size and color
The disease is under control (non-progressive).
Involvement of at least 10% of the body surface
Patients willing to participate in the study
Exclusion Criteria
Use of topical medications in the last month
Having an immune deficiency
Any contraindication for phototherapy such as a history of skin cancer
Pregnant and lactating women
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Severity of vitiligo. Timepoint: Before the intervention, 6 weeks later, 12 weeks later. Method of measurement: Vitiligo Area Scoring Index (VASI).
- Secondary Outcome Measures
Name Time Method